U.s. Food And Drug Administration (fda) - Infectious Diseases

Relevant Publications

Anti-amyloid-β Antibodies and Anti-tau Therapies for Alzheimer\'s Disease: Recent Advances and Perspectives.

Issue Release: 2024

Metformin drugs under simulated gastric conditions can generate high nitrite-dependent levels of N-nitrosodimethylamine.

Issue Release: 2024

Qualitative Analysis of Inquiries Received by FDA Regarding Conduct of Clinical Trials during the Covid-19 Public Health Emergency.

Issue Release: 2024

Direct oral anticoagulant use in hospitalized pediatric patients: Insights from nationwide data.

Issue Release: 2024

Prediction of Response to FDA-Approved Targeted Therapy and Immunotherapy in Acute Lymphoblastic Leukemia (ALL).

Issue Release: 2024

Adverse events in different administration routes of semaglutide: a pharmacovigilance study based on the FDA adverse event reporting system.

Issue Release: 2024

Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment-experienced and/or have multidrug-resistant HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy.

Issue Release: 2024

Artificial Intelligence-Powered Mammography: Navigating the Landscape of Deep Learning for Breast Cancer Detection.

Issue Release: 2024

Fair Balance of Prescription Drug Information on Legitimate and Illegitimate Online Pharmacy Websites.

Issue Release: 2024

Plant-based zinc nanoflowers assisted molecularly imprinted polymer for the design of an electrochemical sensor for selective determination of abrocitinib.

Issue Release: 2024

Evaluating the safety and efficacy of a novel polysaccharide hemostatic system during surgery: A multicenter multispecialty prospective randomized controlled trial.

Issue Release: 2024

Signs and symptoms: Adverse events associated with a sterilization device.

Issue Release: 2024

FDA-cleared home sleep apnea testing devices.

Issue Release: 2024

Patient-centricity in digital measure development: co-evolution of best practice and regulatory guidance.

Issue Release: 2024

Citric Acid: A Nexus Between Cellular Mechanisms and Biomaterial Innovations.

Issue Release: 2024

Adverse event signal mining and serious adverse event influencing factor analysis of fulvestrant based on FAERS database.

Issue Release: 2024

Analysis of the Physicochemical Properties of Anti-Schistosomal Compounds to Identify Next-Generation Leads.

Issue Release: 2024

Implementation status of pharmacological studies in the development of orphan drugs.

Issue Release: 2024

A prospective cohort study of SARS-CoV-2 infection-induced seroconversion and disease incidence in German healthcare workers before and during the rollout of COVID-19 vaccines.

Issue Release: 2024

Use of the Same Model or Modeling Strategy Across Multiple Submissions: Focus on Complex Drug Products.

Issue Release: 2024

How Do Infectious Diseases Affect Lipid Metabolism?

What are the Treatments for Zika Virus?

How Do Antimicrobial Resistance and Infectious Diseases Relate?

What is Chlamydia?

How is HSV Diagnosed?

How are Flaviviridae infections diagnosed?

How Does RT-PCR Work?

Can AI Assist in Diagnostics?

Is Fatigue a Long-term Issue in Infectious Diseases?

What are the Causes?

Partnered Content Networks

Relevant Topics